S100 Proteins as Novel Therapeutic Targets in Psoriasis and Other Autoimmune Diseases
Psoriasis is one of the most common inflammatory skin diseases affecting about 1–3% of the population. One of the characteristic abnormalities in psoriasis is the excessive production of antimicrobial peptides and proteins, which play an essential role in the pathogenesis of the disease. Antimicrobi...
Príomhchruthaitheoirí: | Katarzyna Kurpet, Grażyna Chwatko |
---|---|
Formáid: | Alt |
Teanga: | English |
Foilsithe / Cruthaithe: |
MDPI AG
2022-10-01
|
Sraith: | Molecules |
Ábhair: | |
Rochtain ar líne: | https://www.mdpi.com/1420-3049/27/19/6640 |
Míreanna comhchosúla
Míreanna comhchosúla
-
Study of serum levels and skin expression of S100B protein in psoriasis
de réir: Samar Abdallah M. Salem, et al.
Foilsithe / Cruthaithe: (2017-06-01) -
S100 Proteins in the Pathogenesis of Psoriasis and Atopic Dermatitis
de réir: Natsuko Saito-Sasaki, et al.
Foilsithe / Cruthaithe: (2023-10-01) -
Pathogenic role of S100 proteins in psoriasis
de réir: Huifang Liang, et al.
Foilsithe / Cruthaithe: (2023-06-01) -
S100 Proteins As an Important Regulator of Macrophage Inflammation
de réir: Chang Xia, et al.
Foilsithe / Cruthaithe: (2018-01-01) -
Identifying Predictors of PASI100 Responses up to Month 12 in Patients with Moderate-to-severe Psoriasis Receiving Biologics in the Psoriasis Study of Health Outcomes (PSoHO)
de réir: April W. Armstrong, et al.
Foilsithe / Cruthaithe: (2024-09-01)